XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
ATM offering
Public offering
Common Stock
Common Stock
ATM offering
Common Stock
Public offering
Additional Paid-in Capital
Additional Paid-in Capital
ATM offering
Additional Paid-in Capital
Public offering
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2018       121,482,671              
Beginning balance at Dec. 31, 2018 $ 703,164     $ 121     $ 914,265     $ (211,528) $ 306
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options and vesting of RSU's (in shares)       103,958              
Issuance of common stock upon exercise of stock options and vesting of RSUs 237     $ 1     236        
Vesting of early exercised common stock 3,170           3,170        
Stock-based compensation 19,354           19,354        
Employee stock purchase plan (in shares)       44,649              
Employee stock purchase plan 684           684        
Net loss (72,829)                 (72,829)  
Net unrealized gain on available-for-sale investments 1,855                   1,855
Ending balance (in shares) at Jun. 30, 2019       121,631,278              
Ending balance at Jun. 30, 2019 655,635     $ 122     937,709     (284,357) 2,161
Beginning balance (in shares) at Mar. 31, 2019       121,527,320              
Beginning balance at Mar. 31, 2019 681,228     $ 121     922,816     (243,114) 1,405
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options and vesting of RSU's (in shares)       103,958              
Issuance of common stock upon exercise of stock options and vesting of RSUs 237     $ 1     236        
Vesting of early exercised common stock 3,170           3,170        
Stock-based compensation 11,487           11,487        
Net loss (41,243)                 (41,243)  
Net unrealized gain on available-for-sale investments 756                   756
Ending balance (in shares) at Jun. 30, 2019       121,631,278              
Ending balance at Jun. 30, 2019 $ 655,635     $ 122     937,709     (284,357) 2,161
Beginning balance (in shares) at Dec. 31, 2019 124,267,358     124,267,358              
Beginning balance at Dec. 31, 2019 $ 629,023 [1]     $ 124     1,023,876     (396,122) 1,145
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options and vesting of RSU's (in shares)       853,241              
Issuance of common stock upon exercise of stock options and vesting of RSUs 4,780     $ 1     4,779        
Vesting of early exercised common stock 1,419           1,419        
Stock-based compensation 30,985           30,985        
Employee stock purchase plan (in shares)       84,565              
Employee stock purchase plan 1,438           1,438        
Issuance of common stock from public offering (in shares)         570,839 13,457,447          
Issuance of common stock from public offering   $ 14,845 $ 595,698   $ 1 $ 13   $ 14,844 $ 595,685    
Net loss (115,454)                 (115,454)  
Net unrealized gain on available-for-sale investments $ 685                   685
Ending balance (in shares) at Jun. 30, 2020 139,233,450     139,233,450              
Ending balance at Jun. 30, 2020 $ 1,163,419     $ 139     1,673,026     (511,576) 1,830
Beginning balance (in shares) at Mar. 31, 2020       125,262,537              
Beginning balance at Mar. 31, 2020 606,519     $ 125     1,055,386     (450,602) 1,610
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options and vesting of RSU's (in shares)       513,466              
Issuance of common stock upon exercise of stock options and vesting of RSUs 4,476     $ 1     4,475        
Vesting of early exercised common stock 710           710        
Stock-based compensation 16,770           16,770        
Issuance of common stock from public offering (in shares)       13,457,447              
Issuance of common stock from public offering 595,698     $ 13     595,685        
Net loss (60,974)                 (60,974)  
Net unrealized gain on available-for-sale investments $ 220                   220
Ending balance (in shares) at Jun. 30, 2020 139,233,450     139,233,450              
Ending balance at Jun. 30, 2020 $ 1,163,419     $ 139     $ 1,673,026     $ (511,576) $ 1,830
[1] The balance sheet as of December 31, 2019 is derived from the audited financial statements as of that date.